ACER THERAPEUTICS INC.: 10-K filed 2012-02-27
What ACER THERAPEUTICS INC. reported in its annual report filed 2012-02-27 (fiscal FY 2011): 26 published measures, 76 facts as tagged in accession 0001157523-12-001047.
This filing
- Form
- 10-K (annual report)
- Filed
- 2012-02-27
- Fiscal period
- fiscal FY 2011
- Accession
- 0001157523-12-001047 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ACER THERAPEUTICS INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 8,263,224 | USD | |
| At 2010-12-31 | 4,714,018 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 1,067,860 | USD | |
| At 2010-12-31 | 745,305 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 7,195,364 | USD | |
| At 2010-12-31 | 3,968,713 | USD | |
| At 2009-12-31 | 7,375,148 | USD | |
| At 2008-12-31 | 1,487,397 | USD | |
| At 2007-12-31 | 2,133,585 | USD | |
| At 2006-12-31 | 7,422,898 | USD | |
| At 2005-12-31 | -5,580,034 | USD | |
| At 2004-12-31 | -3,228,942 | USD | |
| At 2003-12-31 | -68,968 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 7,109,215 | USD | |
| At 2010-12-31 | 3,812,535 | USD | |
| At 2009-12-31 | 8,181,582 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -5,968,448 | USD | 365 |
| 2003-01-22 to 2011-12-31 | -100,680,787 | USD | 3266 |
| 2010-01-01 to 2010-12-31 | -5,469,067 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -1,433,922 | USD | 365 |
| 2008-01-01 to 2008-12-31 | -11,852,152 | USD | 366 |
| 2007-01-01 to 2007-12-31 | -14,667,367 | USD | 365 |
| 2006-01-01 to 2006-12-31 | -12,649,170 | USD | 365 |
| 2005-01-01 to 2005-12-31 | -14,856,724 | USD | 365 |
| 2004-01-01 to 2004-12-31 | -31,411,736 | USD | 366 |
| 2003-01-22 to 2003-12-31 | -126,003 | USD | 344 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -4,988,921 | USD | 365 |
| 2003-01-22 to 2011-12-31 | -50,511,688 | USD | 3266 |
| 2010-01-01 to 2010-12-31 | -4,376,013 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 296,949 | USD | 365 |
| 2003-01-22 to 2011-12-31 | 1,671,810 | USD | 3266 |
| 2010-01-01 to 2010-12-31 | 35,350 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 8,582,550 | USD | 365 |
| 2003-01-22 to 2011-12-31 | 59,292,713 | USD | 3266 |
| 2010-01-01 to 2010-12-31 | 42,316 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -296,949 | USD | 365 |
| 2003-01-22 to 2011-12-31 | -1,671,810 | USD | 3266 |
| 2010-01-01 to 2010-12-31 | -35,350 | USD | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 1,029,236 | USD | |
| At 2010-12-31 | 815,958 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 489,914 | USD | 365 |
| 2003-01-22 to 2011-12-31 | 15,575,207 | USD | 3266 |
| 2010-01-01 to 2010-12-31 | 508,550 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -5,966,245 | USD | 365 |
| 2003-01-22 to 2011-12-31 | -99,644,679 | USD | 3266 |
| 2010-01-01 to 2010-12-31 | -4,970,079 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 7,233,988 | USD | |
| At 2010-12-31 | 3,898,060 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 3,135 | USD | 365 |
| 2003-01-22 to 2011-12-31 | 9,056,959 | USD | 3266 |
| 2010-01-01 to 2010-12-31 | 500,648 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 1,067,860 | USD | |
| At 2010-12-31 | 745,305 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 476,315 | USD | |
| At 2010-12-31 | 358,837 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2003-01-22 to 2011-12-31 | 325 | USD | 3266 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 3,340,038 | USD | 365 |
| 2003-01-22 to 2011-12-31 | 70,178,875 | USD | 3266 |
| 2010-01-01 to 2010-12-31 | 2,584,734 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 23,048,488 | shares | |
| At 2010-12-31 | 18,466,924 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 107,645,666 | USD | |
| At 2010-12-31 | 98,496,382 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 1,193,601 | USD | |
| At 2010-12-31 | 1,109,558 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 576,545 | USD | |
| At 2010-12-31 | 335,861 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 2,406,269 | USD | 365 |
| 2003-01-22 to 2011-12-31 | 27,609,075 | USD | 3266 |
| 2010-01-01 to 2010-12-31 | 2,216,043 | USD | 365 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2003-01-22 to 2011-12-31 | 661,146 | USD | 3266 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -26,245 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 26,245 | USD | 365 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -13,028 | USD | 365 |
| 2003-01-22 to 2011-12-31 | -89,241 | USD | 3266 |
| 2010-01-01 to 2010-12-31 | -251,765 | USD | 365 |
Inspect the source
- Entity
- ACER THERAPEUTICS INC. / CIK 0001069308
- Captured
- SEC response SHA-256
d41ecd9c66d537efeeb403c8604fe32734f808b5d83b00a9acc9f0ba72164b38
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001069308.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))